Michael Beyeler

Michael Beyeler

Auto-generated profile, based on publicly available information

Michael Beyeler

Department of Computational Biology, University of Lausanne, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
GCGiulia Cappi
Giulia Cappi
FSFabio M. Spiga
Fabio M. Spiga
YMYessica Moncada
Yessica Moncada
AFAnna Ferretti
Anna Ferretti
MBMichael Beyeler
Michael Beyeler
CGCarlotta Guiducci
Carlotta Guiducci

6 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
SVSofía Ortín Vela
Sofía Ortín Vela
MBMichael J. Beyeler
Michael J. Beyeler
OTOlga Trofimova
Olga Trofimova
IIIlaria Iuliani
Ilaria Iuliani
JQJose D. Vargas Quiros
Jose D. Vargas Quiros
SBSven Bergmann
Sven Bergmann
Fundus images allow for non-invasive assessment of the retinal vasculature whose features provide important information on health. Using a fully automated image processing pipeline, we extract 17 different morphological vascular phenotypes, including median vessels diameter, diameter variability, main temporal angles, vascular density, central retinal equivalents, the number of bifurcations, and tortuosity, from over 130,000 fundus images of close to 72,000 UK Biobank subjects. We perform genome-wide association studies of these phenotypes. From this, we estimate their heritabilities, ranging between 5 and 25%, and genetic cross-phenotype correlations, which mostly mirror the corresponding phenotypic correlations, but tend to be slightly larger. Projecting our genetic association signals onto genes and pathways reveals remarkably low overlap suggesting largely decoupled mechanisms modulating the different phenotypes. We find that diameter variability, especially for the veins, associates with diseases including heart attack, pulmonary embolism, and age of death. Mendelian Randomization analysis suggests a causal influence of blood pressure and body mass index on retinal vessel morphology, among other results. We validate key findings in two independent smaller cohorts. Our analyses provide evidence that large-scale analysis of image-derived vascular phenotypes has sufficient power for obtaining functional and causal insights into the processes modulating the retinal vasculature.

26 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
MTMattia Tomasoni
Mattia Tomasoni
MBMichael Johannes Beyeler
Michael Johannes Beyeler
SVSofia Ortin Vela
Sofia Ortin Vela
NMNinon Mounier
Ninon Mounier
EPEleonora Porcu
Eleonora Porcu
SBSven Bergmann
Sven Bergmann
Background: Fundus images allow for non-invasive assessment of the retinal vasculature whose features provide important information on health. Blood vessel tortuosity is a morphological feature associated with many diseases including hypertension. Methods: We analyzed 116 639 fundus images of suitable quality from 63 662 participants from three cohorts, namely the UK Biobank (n = 62 751), SKIPOGH (n = 397), and OphtalmoLaus (n = 512). We used a fully automated image processing pipeline to annotate vessels and a deep learning algorithm to determine the vessel type, characterizing these subjects in terms of their median retinal vessel tortuosity specific to arteries and to veins. Tortuosity was measured by the distance factor (the length of a vessel segment over its chord length), as well as measures that integrate over vessel curvature. Using these measures as traits, we performed the largest genome-wide association study (GWAS) of vessel tortuosity to date. We assessed gene set enrichment using the novel high-precision statistical method PascalX . Results: Higher tortuosity was significantly associated with higher incidence of angina, myocardial infarction, stroke, deep vein thrombosis, and hypertension. We identified 175 significantly associated genetic loci in the UK Biobank; 173 of these were novel and 4 replicated in our second, much smaller, meta-cohort. We estimated heritability at ∼25% using linkage disequilibrium score regression. Vessel type specific GWAS revealed 114 loci for arteries and 63 for veins. Genes with significant association signals included COL4A2, ACTN4, LGALS4, LGALS7, LGALS7B, TNS1, MAP4K1, EIF3K, CAPN12, ECH1, and SYNPO2. These tortuosity genes were overexpressed in arteries and heart muscle and linked to pathways related to the structural properties of the vasculature. We demonstrated that tortuosity loci served pleiotropic functions as cardiometabolic disease variants and risk factors. Concordantly, Mendelian randomization revealed causal effects between tortuosity, BMI and LDL. Conclusions: Several alleles associated with retinal vessel tortuosity point to a common genetic architecture of this trait with cardiovascular diseases and metabolic syndrome. Our results shed new light on the genetics of vascular diseases and their pathomechanisms and highlight how GWASs and heritability can be used to improve phenotype extraction from high-dimensional data, such as images. Clinical Perspective: What is new?: We automatically estimated arterial and venous tortuosity in over 100k retinal fundus images using image analysis and deep learning. GWAS revealed 173 novel loci. Mendelian randomization showed that increased venous tortuosity reduces BMI whereas elevated LDL levels reduce the tortuosity of both arteries and veins. Measuring tortuosity in terms of the distance factor , which is sensitive to total vessel elongation, had higher heritability and more associated loci than other tortuosity measures that are sensitive to local vessel bending. What are the clinical implications?: Tortuosity genes were overexpressed in the aorta, tibial artery, coronary artery, and in two heart tissues. Higher tortuosity was associated with higher incidence of angina, myocardial infarction, stroke, deep vein thrombosis and hypertension. We demonstrated a shared genetic architecture between retinal tortuosity and certain diseases related to the vasculature, and the associations included several cardiometabolic disease variants and risk factors. Further research is needed to investigate the potential of the retinal vessel tortuosity as a clinically relevant biomarker for cardiovascular disease and metabolic syndrome. Enriched pathways include a well-known therapeutic target for ocular diseases (VEGFA-VEGFR2) affecting tissue remodeling. We highlight several transcription factors as interesting targets for further experimentation.

1 October 2025 in Journal of Vision
Verified
Journal Article
Open access
RERebecca B. Esquenazi
Rebecca B. Esquenazi
KMKimberly Meier
Kimberly Meier
MBMichael Beyeler
Michael Beyeler
DWDrake Wright
Drake Wright
GBGeoffrey M. Boynton
Geoffrey M. Boynton
IFIone Fine
Ione Fine
A key limitation shared by both electronic and optogenetic sight recovery technologies is that they cause simultaneous rather than complementary firing within on- and off-center cells. Here, using "virtual patients"-sighted individuals viewing distorted input-we examine whether gamified training improves the ability to compensate for distortions in neuronal population coding. We measured perceptual learning using dichoptic input, filtered so that regions of the image that produced on-center responses in one eye produced off-center responses in the other eye. The Non-Gaming control group carried out an object discrimination task over five sessions using this filtered input. The Gaming group carried out an additional 25 hours of gamified training using a similarly filtered variant of the video game Fruit Ninja. Both groups showed improvements over time in the object discrimination task. However, there was no significant transfer of learning from the "Fruit Ninja" task to the object discrimination task. The lack of transfer of learning from video game training to object recognition suggests that gamification-based rehabilitation for sight recovery technologies may have limited utility and may be most effective when targeted on learning specific visual tasks.

18 July 2025 in bioRxiv
Verified
Preprint
Open access
LBLeah Böttger
Leah Böttger
DBDennis Bontempi
Dennis Bontempi
OTOlga Trofimova
Olga Trofimova
MBMichael J Beyeler
Michael J Beyeler
SBSacha Bors
Sacha Bors
SBSven Bergmann
Sven Bergmann
Sex as a biological variable (SABV) remains underemphasized in biomedical research, despite its well-established impact on disease prevalence, progression, and genetic architecture. Here, we investigated sex differences in retinal vascular phenotypes, which are emerging as non-invasive biomarkers for ocular, cardiovascular, and neurodegenerative diseases. We used both interaction and sex-stratified analyses in disease association and genome-wide association studies (GWAS), including the X chromosome. Our analyses revealed sex-specific differences in associations between retinal traits, cardiometabolic risk factors, and disease outcomes. Several phenotypes showed prognostic value for mortality and cardiovascular endpoints, predominantly in one sex, illustrating the limitations of sex-agnostic analyses. Genetic analyses revealed differences in genetic architectures, with females exhibiting higher heritability and a greater number of associated loci, as well as sex-specific trait-gene associations. Notably, we report the first genetic association on the X chromosome for retinal vascular phenotypes. These findings suggest sex-differential genetic and environmental contributions to microvascular morphology, possibly reflecting divergent biological pathways and risk profiles. Our study underscores the necessity of integrating SABV and sex-aware approaches in genetic and prognostic research to advance precision medicine and improve tailored risk stratification.

27 December 2024 in medRxiv
Verified
Preprint
Open access
PDF file
MBMichael J. Beyeler
Michael J. Beyeler
OTOlga Trofimova
Olga Trofimova
DBDennis Bontempi
Dennis Bontempi
JQJosé Vargas Quiros
José Vargas Quiros
IMIlenia Meloni
Ilenia Meloni
SBSven Bergmann
Sven Bergmann
Advances in AI, including deep learning (DL), are transforming medical image analysis by enabling automated disease risk predictions. However, DL’s outputs and latent space representations often lack interpretability, impeding clinical trust and biological insight. In this study, we evaluated RETFound , a foundation model for retinal images, by comparing its predictive performance and genetic associations to those obtained using clinically interpretable tangible image features (TIFs). Our findings revealed that fine-tuning RETFound to predict TIFs provides reasonable estimates for simpler TIFs, like vessel densities ( R 2 = 0.91-0.93), but much less accurate approximations for more complex TIFs, like vessel tortuosities ( R 2 = 0.25-0.43), highlighting RETFound’s limitations to fully characterise the retinal vasculature. We also utilized genome wide association studies on RETFound ’s latent space, the predicted TIFs, and their measured counterparts to better understand the physiological features that RETFound may be focusing on. We find that its latent space variables have many genetic associations, in particular with pathways involved in pigmentation, but only a small overlap with the significant genes identified from measured or predicted TIFs. Analysing the predictive value of the latent space variables, predicted and measured TIFs for clinical endpoints, we find that hybrid models that include all these features perform best for predicting blood pressure and body mass index, indicating that augmenting deep learning models with manually curated features may improve overall prediction capacity. Overall, this study highlights the synergistic potential of integrating deep learning with classical feature extraction, advancing our understanding of retinal biology and disease mechanisms, and paving the way toward improved diagnostic and prognostic tools in ophthalmology.